Tryptamines

DBCAT001049Pharmacologic class

Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS. A DrugBank category of 10 drugs. 2 of them are approved.

Also known as: Indolylethylamines
Drugs: 5-Methoxy-N,N-diisopropyltryptamine
5-methoxy-N,N-dimethyltryptamine
Bufotenine
Dimethyltryptamine
Melatonin
N-acetylserotonin
Psilocybin
Serotonin
Sumatriptan
TIK-301

What you can answer from here — as of September 25, 2018

10DrugsEach linked to its full drug card

Listed above

27Drug targetsEvery drug–target pair in the class, with bond type

1,056Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

Which targets do Tryptamines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account